Delaware Chapter of the American College of CardiologyOur purpose is to contribute to the prevention of cardiovascular diseases, to ensure optimal quality of care for individuals with such diseases, and to foster the highest professional ethical standards. Please let us know what information you want to see here. Feel free to contact us with your ideas, needs and comments. |
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Latest in Cardiology from ACC.org
- FDA Update: Empty IV Containers Added to Medical Device Shortages ListThe U.S. Food and Drug Administration's (FDA's) Center for Devices and Radiological Health (CDRH) announced the addition of empty intravenous (IV) containers to the agency's Medical Device Shortages List on Dec. 4.
- Edoxaban Versus Edoxaban With Antiplatelet Agent in Patients With Atrial Fibrillation and Chronic Stable Coronary Artery DiseaseThe goal of the EPIC-CAD trial was to evaluate edoxaban monotherapy compared with edoxaban/antiplatelet therapy among patients with atrial fibrillation (AF) and chronic coronary disease.
- RVOT Dysfunction in Repaired TOF: Key PointsThe following are key points to remember from an American Heart Association scientific statement on the long-term management of right ventricular outflow tract (RVOT) dysfunction in repaired tetralogy of Fallot (TOF).
- ACC CardiaCast: Courtside with the Chair: The Emergence of Pediatric Sports Cardiology, Part 1"Courtside with the Chair" is a series within CardiaCast presented by the Sports and Exercise Cardiology Member Section covering topics within the field of sports and exercise cardiology.
- PCI vs. CABG for NSTEMI With Multivessel CADWhat are the long-term outcomes of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in patients with non-ST-segment elevation myocardial infarction (NSTEMI) and multivessel disease?